Ascomya PK88™

A New Frontier in Fungal Probiotics
Scroll to introduction
PK88™ is a novel probiotic yeast discovered through Biohm’s Symbiont® platform.

The first Pichia kluyveri strain developed as a probiotic


At the heart of Biohm Technologies’ Ascomya™ fungal probiotic platform is PK88™—the first Pichia kluyveri strain developed as a probiotic. Discovered through Symbiont®, PK88™ has a distinctive profile: beta-glucans in its cell wall, antioxidant systems, and the ability to produce bioactive metabolites.

Microscope image of Pichia kluyveri cells at 100x, with beta-glucans highlighted in teal.

Beta-glucans visualized in the PK88™ cell wall.

PK88™ characteristics

Antioxidant systems

Beta-glucans

Bioactive metabolites

Beyond Bacteria

Why Fungi Matter in the Microbiome
Bacteria

More numerous, smaller cells

Fungi

Fewer, much larger cells

Two kingdoms,
one microbiome

Fungi are less numerous than bacteria in the gut, but their cells are generally much larger⁠—​and the two communities interact closely.


Those relationships can influence how microbes grow and behave, adding a dimension to the microbiome that we’re only beginning to explore. For product developers, that opens up possibilities beyond familiar bacterial strains.

From Data to Discovery

Discovery Guided by Symbiont®

Biohm’s proprietary gut microbiome data

Pichia identified in healthy microbial communities

Multiple strains screened for safety and functional potential

PK88™ selected

Whole genome sequencing and extensive characterization

Biohm’s proprietary gut microbiome data highlighted Pichia in healthy microbial communities, prompting a closer look at strains with promising safety and functional profiles. PK88™ emerged from that screening and has since undergone whole genome sequencing and extensive characterization to better understand its potential as a probiotic.

Emerging Preclinical Data

Why PK88™ Stands Out

Biohm’s emerging preclinical data1 reveal a distinctive functional profile for PK88™:

Beta-glucans

Beta-glucans in its cell wall offer prebiotic potential and a new angle on microbiome support

GABA & B Vitamins

PK88™ produces GABA and B vitamins, with potential relevance to mood and the gut‑brain axis

Spermidine & Antioxidants

Spermidine production and antioxidant systems offer avenues to explore cellular health and healthy aging

These findings are driving ongoing human clinical research.

Woman holding a glass of water in a bright kitchen with a fruit bowl.

Formulating with PK88™

A Novel Probiotic Yeast for Your Next Product

PK88™ is recommended at 100 million CFU and is suitable for capsules, tablets and powders. As the first ingredient in the Ascomya™ fungal probiotic platform, it offers a differentiated option for brands expanding beyond traditional bacterial probiotics.

Recommended at 100 million

CFU

Suitable for

Capsules

Tablets

Powders

PK88
Woman holding a glass of water in a bright kitchen with a fruit bowl.

Quality Attributes

GRAS status

Kosher

Non-GMO

Vegan suitable

Allergen free
Woman taking a capsule with a glass of water in a kitchen.
Bring the fungal side of the microbiome into your next probiotic product. Contact us today to explore formulating with Ascomya PK88™.